Gabay, Cem

 
Title Year Hits Downloads
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype 2017 36 11
Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis 2017 5 0
The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis 2017 6 0
The role of female hormonal factors in the development of rheumatoid arthritis 2017 29 0
Elevated serum levels of free interleukin-18 in adult-onset Still's disease 2016 16 0
Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice 2016 115 2
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid Cells 2016 33 0
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis 2016 88 0
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis 2016 19 0
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study 2016 70 0
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype 2016 38 0
Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease 2016 76 1
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis 2016 82 29
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling 2015 101 15
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice 2015 213 1
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study 2015 138 266
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry 2015 85 0
Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system 2015 229 3
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists 2015 68 0
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection 2015 71 41
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study 2015 91 0
Inflammation: IL-36 has proinflammatory effects in skin but not in joints 2014 166 0
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee 2014 143 0
Immune-mediated experimental arthritis in IL-33 deficient mice 2014 192 1
Biological agents in monotherapy for the treatment of rheumatoid arthritis 2014 170 2
Efficacy of intra-articular bevacizumab for relapsing diffuse-type giant cell tumour 2014 199 2
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 2014 103 87
In Black Africans with rheumatoid arthritis, ACPA recognize citrullinated fibrinogen and the derived peptides α36-50Cit38,42 and β60-74Cit60,72,74, like in Caucasians 2014 182 1
Joint damage progression in patients with rheumatoid arthritis in clinical remission. Do biologics perform better than synthetic antirheumatic drugs? 2014 93 0
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout 2014 196 0
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience 2013 243 95
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions 2013 132 118
The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans 2013 167 55
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions 2013 182 120
Endogenous IL-1α is a chromatin-associated protein in mouse macrophages 2013 169 1
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis" 2013 129 0
The severity of experimental arthritis is independent of IL-36 receptor signaling 2013 180 46
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply 2013 135 0
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial 2013 134 0
Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome 2013 151 0
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency 2013 205 55
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement 2013 167 71
Hand osteoarthritis: new insights 2013 185 0
Do synovial leptin levels correlate with pain in end stage arthritis? 2013 218 1
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial 2012 232 0
Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments 2012 116 1
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration 2012 182 0
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? 2012 228 1
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis 2012 253 410
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis 2012 136 3
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells 2012 216 215
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease 2012 223 100
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists 2012 146 198
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients 2012 193 0
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice 2012 194 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study 2011 257 2
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions 2011 217 0
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection 2011 190 0
Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center 2011 182 0
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis 2011 224 185
IL-33 biology with potential insights into human diseases 2011 185 0
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis 2011 192 0
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries 2011 117 0
IL-36R ligands are potent regulators of dendritic and T cells 2011 196 0
The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study 2011 186 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients 2011 346 253
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters 2011 193 1
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients 2010 221 302
Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins 2010 133 320
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? 2010 171 0
Polyarthrite rhumatoïde,méthotrexate et fibrose pulmonaire : quelles évidences ? 2010 294 0
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis 2010 219 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs 2010 183 0
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice 2010 122 0
The effect of alcohol on radiographic progression in rheumatoid arthritis 2010 190 0
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial 2010 198 0
Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist 2010 187 0
IL-1 pathways in inflammation and human diseases 2010 238 0
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients 2010 192 0
Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists 2010 280 0
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis 2009 197 1
Mutations in the IL1RN locus lead to autoinflammation 2009 187 1
Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaounde-Cameroon 2009 167 0
Interleukin-33 is biologically active independently of caspase-1 cleavage 2009 127 225
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases 2009 173 0
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis 2009 180 0
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory 2009 175 2
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure 2009 114 0
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice 2009 320 578
The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study 2009 145 7
Synovial tissues concentrate secreted APRIL 2009 193 200
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis 2009 180 0
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies 2009 232 147
Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis? 2008 190 1
Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc 2008 193 0
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 2008 188 0
At the horizon of innovative therapy in rheumatology: new biologic agents 2008 181 9
The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14 2008 186 0
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease 2008 189 0
IL-1, IL-18, and IL-33 families of cytokines 2008 292 951
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells 2007 135 0
Expression and function of junctional adhesion molecule-C in human and experimental arthritis 2007 201 149
Molecular Characterization and Subcellular Localization of Macrophage Infectivity Potentiator, a Chlamydia trachomatis Lipoprotein 2007 207 385
Leukocyte migration to rheumatoid joints: Enzymes take over 2006 163 1
Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis 2006 164 0
The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes 2006 195 76
Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility 2005 118 147
Total hip prosthetic joint infection due to Veillonella species 2004 192 0
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice 2004 85 35
17951 5931